Mr. John Fowler reports

SUPREME COMPLETES OPERATIONAL TRANSITION TO ONTARIO

Supreme Pharmaceuticals Inc. has completed its operational transition from British Columbia to Ontario in order to focus resources on the Kincardine facility. The transition allows the company to reduce operating overhead and focus efforts on obtaining required regulatory approvals at the Kincardine facility.

Further to the transition, Brayden Sutton will be resigning as executive vice-president, effective immediately, but will continue on with company as a consultant for the near term to assist in completing the company's operational transition.

John Fowler, president of the company, stated: "Refocusing our attention on Ontario is a big step in our journey to become a leading supplier of affordable medical marijuana in Canada. It allows us to concentrate on building our business around our flagship greenhouse facility. With our focus set squarely on Kincardine, I feel we are well positioned for future success."

Currently, the company continues to prepare for its postlicence operations by engaging with various health care providers, patient groups and wholesale partners. At present, no date has been set for the prelicence regulatory inspection.

We seek Safe Harbor.